We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
TEICOPLANIN MEDICIANZ (Medicianz Healthcare Pty Ltd)
Product name
TEICOPLANIN MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
137 (255 working days)
Active ingredients
teicoplanin
Registration type
New generic medicine
Indication
Teicoplanin is indicated for the treatment of the following infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including B-lactam antibiotics:
Bone – osteomyelitis
Joints - septic arthritis
Blood - non-cardiac bacteraemia, septicaemia.